BIOMAT Database Logo BIOMAT Database Logo

A new peptidic vector for molecular imaging of apoptosis, identified by phage display technology. 2006

Catherine Laumonier, and Jérôme Segers, and Sophie Laurent, and Alain Michel, and Frédérique Coppée, and Alexandra Belayew, and Luce Vander Elst, and Robert N Muller
Department of General, Organic and Biomedical Chemistry, NMR and Molecular Imaging Laboratory, University of Mons-Hainaut, Mons, Belgium.

Phosphatidylserine (PS) exposure on the cell surface is an early marker of apoptosis. To select PS binding peptides as vectors of contrast agents to image apoptosis, a phage library has been exposed to perfused mouse livers. Phages not retained on control livers during the first perfusions were used for selections on apoptotic livers in a second series of perfusions. Four selected phages were further evaluated for binding to PS-coated enzyme-linked immunosorbent assay (ELISA) plates. They presented an apparent affinity constant (Ka app) for PS ranging from 6.08x10(10) M to 1.62x10(11)M. These phages did not bind to phosphatidylcholine, and competition with annexin V confirmed their specific interaction with PS. The phage with the highest affinity-bound PS in ELISA with a Ka app=(1.6+/-0.2)x10(11)M. It carried the TLVSSL peptide that was synthesized. Specific competition with annexin V and with the synthetic peptide was performed and confirms the specificity of the interaction.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D010718 Phosphatidylserines Derivatives of PHOSPHATIDIC ACIDS in which the phosphoric acid is bound in ester linkage to a SERINE moiety. Serine Phosphoglycerides,Phosphatidyl Serine,Phosphatidyl Serines,Phosphatidylserine,Phosphoglycerides, Serine,Serine, Phosphatidyl,Serines, Phosphatidyl
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D003287 Contrast Media Substances used to allow enhanced visualization of tissues. Radiopaque Media,Contrast Agent,Contrast Agents,Contrast Material,Contrast Materials,Radiocontrast Agent,Radiocontrast Agents,Radiocontrast Media,Agent, Contrast,Agent, Radiocontrast,Agents, Contrast,Agents, Radiocontrast,Material, Contrast,Materials, Contrast,Media, Contrast,Media, Radiocontrast,Media, Radiopaque
D003952 Diagnostic Imaging Any visual display of structural or functional patterns of organs or tissues for diagnostic evaluation. It includes measuring physiologic and metabolic responses to physical and chemical stimuli, as well as ultramicroscopy. Imaging, Diagnostic,Imaging, Medical,Medical Imaging
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Catherine Laumonier, and Jérôme Segers, and Sophie Laurent, and Alain Michel, and Frédérique Coppée, and Alexandra Belayew, and Luce Vander Elst, and Robert N Muller
Identification of ligand-selective peptidic ActRIIB-antagonists using phage display technology.
September 2017, Biochemistry and biophysics reports,
Catherine Laumonier, and Jérôme Segers, and Sophie Laurent, and Alain Michel, and Frédérique Coppée, and Alexandra Belayew, and Luce Vander Elst, and Robert N Muller
Phage display screening for peptidic chitinase inhibitors.
January 2008, Journal of molecular recognition : JMR,
Catherine Laumonier, and Jérôme Segers, and Sophie Laurent, and Alain Michel, and Frédérique Coppée, and Alexandra Belayew, and Luce Vander Elst, and Robert N Muller
Phage display applications for molecular imaging.
September 2010, Current pharmaceutical biotechnology,
Catherine Laumonier, and Jérôme Segers, and Sophie Laurent, and Alain Michel, and Frédérique Coppée, and Alexandra Belayew, and Luce Vander Elst, and Robert N Muller
Generation of peptides using phage display technology for cancer diagnosis and molecular imaging.
May 2023, Molecular biology reports,
Catherine Laumonier, and Jérôme Segers, and Sophie Laurent, and Alain Michel, and Frédérique Coppée, and Alexandra Belayew, and Luce Vander Elst, and Robert N Muller
A new peptide ligand for targeting human carbonic anhydrase IX, identified through the phage display technology.
December 2010, PloS one,
Catherine Laumonier, and Jérôme Segers, and Sophie Laurent, and Alain Michel, and Frédérique Coppée, and Alexandra Belayew, and Luce Vander Elst, and Robert N Muller
A new TAG-72 cancer marker peptide identified by phage display.
December 2008, Cancer letters,
Catherine Laumonier, and Jérôme Segers, and Sophie Laurent, and Alain Michel, and Frédérique Coppée, and Alexandra Belayew, and Luce Vander Elst, and Robert N Muller
Phage display technology.
January 2000, Methods in molecular medicine,
Catherine Laumonier, and Jérôme Segers, and Sophie Laurent, and Alain Michel, and Frédérique Coppée, and Alexandra Belayew, and Luce Vander Elst, and Robert N Muller
Making antibodies by phage display technology.
January 1994, Annual review of immunology,
Catherine Laumonier, and Jérôme Segers, and Sophie Laurent, and Alain Michel, and Frédérique Coppée, and Alexandra Belayew, and Luce Vander Elst, and Robert N Muller
Optimization of peptidic HIV-1 fusion inhibitor T20 by phage display.
August 2019, Protein science : a publication of the Protein Society,
Catherine Laumonier, and Jérôme Segers, and Sophie Laurent, and Alain Michel, and Frédérique Coppée, and Alexandra Belayew, and Luce Vander Elst, and Robert N Muller
HMGA Interactome: new insights from phage display technology.
May 2011, Biochemistry,
Copied contents to your clipboard!